FI86727B - Foerfarande foer framstaellning av terapeutiskt anvaendbara 2-fenyl- eller halogenfenyl-7,8,9,10 -tetrahydropyrido/e//1,2,4/triazolo/1,5-c/-pyrimidoner. - Google Patents
Foerfarande foer framstaellning av terapeutiskt anvaendbara 2-fenyl- eller halogenfenyl-7,8,9,10 -tetrahydropyrido/e//1,2,4/triazolo/1,5-c/-pyrimidoner. Download PDFInfo
- Publication number
- FI86727B FI86727B FI882081A FI882081A FI86727B FI 86727 B FI86727 B FI 86727B FI 882081 A FI882081 A FI 882081A FI 882081 A FI882081 A FI 882081A FI 86727 B FI86727 B FI 86727B
- Authority
- FI
- Finland
- Prior art keywords
- compound
- triazolo
- compounds
- formula
- tetrahydropyrido
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pulmonology (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Physical Or Chemical Processes And Apparatus (AREA)
- Phenolic Resins Or Amino Resins (AREA)
Claims (3)
1. Förfarande för framställning av 2-fenyl- eller halofenyl-tetrahydro-pyrido[e][1,2,4]triazolo[1,5-c]pyrimidoner, vilka Sr lämpliga som bensodiazepinreceptoragonister/antagonister och vilka har formeln Ia /R’ r'N^yVn L ’ 1 o*) H 25 86727 i vilken R Sr a-metylbensyl, karbamoyl, fenylsulfonyl, kar-boximetyl, lägalkoxikarbonylmetyl, karbamoylmetyl, cyanome-tyl, pyridylmetyl eller tetrazolylmetyl och R^ betecknar fe-nyl eller halofenyl, tautomerer och farmaceutiskt godtagbara salter dSrav, kännetecknat därav, att en före-ning med formeln X %^vCN kAz (x) i vilken R' Sr vSte, lägalkoxikarbonyl eller R, som betecknar detsamma som ovan, och Z Sr -NCH(=0)-lägalkyl, omsSttes med en hydra2id med formeln XI 0=C-Rx NH (χΙ) / h2n i vilken R! betecknar detsamma som ovan, och, vid behov, en erhällen förening, i vilken R' betecknar lägalkoxikarbo-nyl, hydrolyseras och a) en erhällen förening alkyleras eller b) en erhällen förening acyleras eller c) en erhällen förening sulfoneras eller d) en erhällen förening alkyleras och hydrolyseras eller e) en erhällen förening alkyleras, hydrolyseras och ami-deras eller f) en erhällen förening karbamoyleras eller 26 86727 g) en erhällen förening alkyleras och den erhällna resten R omvandlas tili en tetrazolylring, och/eller ett sait överföres i en fri förening eller i ett annat sait och/eller en erhällen fri förening, vilken har en saltbildande grupp, överföres i ett farmaceutiskt godtagbart sait.
2. Förfarande enligt patentkravet 1, känneteck-n a t därav, att man framställer 2-(2-fluorfenyl)-9-(3-pikolyl)-7,8,9,10-tetrahydropyrido-[3,4-e][1,2,4]triazolo[1,5-c]pyrimidin-5(6H)on eller farmaceutiskt godtagbara salter därav.
3. Förfarande enligt patentkravet l, känneteck-n a t därav, att man framställer 9-etoxikarbonylmetyl-2-(2-fluorfenyl)-7,8,9,10-tetrahyd-ropyridof 3,4-e][1,2,4]triazolo[1,5-c]pyrimidin-5(6H)on och farmaceutiskt godtagbara salter därav.
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US91317386A | 1986-09-30 | 1986-09-30 | |
US91317386 | 1986-09-30 | ||
US2005587 | 1987-02-27 | ||
US07/020,055 US4831013A (en) | 1986-03-20 | 1987-02-27 | 2-substituted-e-fused-[1,2,4]triazolo[1,5-c]pyrimidines, pharmaceutical compositions, and uses thereof |
PCT/EP1987/000547 WO1988002370A1 (en) | 1986-09-30 | 1987-09-25 | 2-substituted-e-fused-[1,2,4]triazolo[1,5-c]pyrimidines pharmaceutical compositions and uses thereof |
EP8700547 | 1987-09-25 | ||
CN89106168 | 1989-08-03 | ||
CN89106168A CN1049120A (zh) | 1986-09-30 | 1989-08-03 | 制取合成材料的方法 |
Publications (4)
Publication Number | Publication Date |
---|---|
FI882081A0 FI882081A0 (fi) | 1988-05-04 |
FI882081A FI882081A (fi) | 1988-05-04 |
FI86727B true FI86727B (fi) | 1992-06-30 |
FI86727C FI86727C (sv) | 1992-10-12 |
Family
ID=36741346
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI882081A FI86727C (sv) | 1986-09-30 | 1988-05-04 | Förfarande för framställning av terapeutiskt användbara 2-fenyl- eller halogenfenyl-7,8,9,10-tetrahydropyrido/e//1,2,4/triazolo/1,5-c/-pyrim idoner |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0263071B1 (sv) |
JP (1) | JPH06104666B2 (sv) |
CN (1) | CN1049120A (sv) |
AT (1) | ATE79380T1 (sv) |
AU (1) | AU612331B2 (sv) |
CA (1) | CA1317590C (sv) |
DE (1) | DE3781080T2 (sv) |
DK (1) | DK289888A (sv) |
ES (1) | ES2051772T3 (sv) |
FI (1) | FI86727C (sv) |
GR (1) | GR3006247T3 (sv) |
IE (1) | IE59815B1 (sv) |
WO (1) | WO1988002370A1 (sv) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1331178C (en) * | 1988-02-05 | 1994-08-02 | James J. Wade | Triazolo ¬1,5-c| pyrimido ¬1,4| azines as bronchodilators |
US5173492A (en) * | 1989-09-14 | 1992-12-22 | Kyowa Hakko Kogyo Co., Ltd. | s-Triazolo(3,4-I)purine derivatives |
CA2029651C (en) * | 1989-11-17 | 2000-06-06 | David D. Davey | Tricyclic pteridinones and a process for their preparation |
US5095015A (en) * | 1990-07-24 | 1992-03-10 | Neurogen Corporation | Certain azacycloalkyl imidazopyrimidines; a new class of gaba brain receptor ligands |
US5185446A (en) * | 1990-09-04 | 1993-02-09 | Neurogen Corporation | Certain cycloalkyl imidazopyrimidines; a new class of gaba brainreceptor ligands |
US5206222A (en) * | 1991-05-22 | 1993-04-27 | Vanderbilt University | Methods for the reduction of myocardial reperfusion injury |
GB9111130D0 (en) * | 1991-05-23 | 1991-07-17 | Ici Plc | Azole derivatives |
GB9111131D0 (en) * | 1991-05-23 | 1991-07-17 | Ici Plc | Heterocyclic compounds |
GB9125002D0 (en) * | 1991-11-25 | 1992-01-22 | Ici Plc | Azole derivatives |
IT1264901B1 (it) * | 1993-06-29 | 1996-10-17 | Schering Plough S P A | Analoghi eterociclici di 1,2,4-triazolo(15-c)pirimidine ad attivita' antagonista per il recettore a2 dell'adenosina |
ATE208199T1 (de) * | 1993-07-27 | 2001-11-15 | Kyowa Hakko Kogyo Kk | Arzneimittel gegen parkinsonsche krankheit |
US5677309A (en) * | 1996-03-22 | 1997-10-14 | Neurogen Corporation | 1,2,4-triazolo 4,3-c! quinazolin-3-ones and 1,2,4-triazolo 4,3-c!quinazolin-3-thiones; a new class of GABA brain receptor ligands |
US5955465A (en) * | 1996-03-22 | 1999-09-21 | Neurogen Corporation | 1,2,4-triazolo 4,3-c!quinazolin-3-ones and 1,2,4-triazolo 4,3-c!quinazolin-3-thiones |
CN1060698C (zh) * | 1996-04-26 | 2001-01-17 | 清华大学 | 可完成多种快速原型制造工艺的多功能设备 |
CN1061279C (zh) * | 1996-06-21 | 2001-01-31 | 李琎 | 制造铁铝或铁三铝金属间化合物零件的方法 |
JP4195729B2 (ja) | 1997-03-24 | 2008-12-10 | 協和醗酵工業株式会社 | [1,2,4]トリアゾロ[1,5−c]ピリミジン誘導体 |
CA2326716C (en) * | 1998-04-03 | 2006-12-12 | Otsuka Pharmaceutical Factory, Inc. | Triazolopurine derivative, pharmaceutical composition containing the derivative, adenosine a3 receptor ligand, and remedy for asthma |
DE19826843A1 (de) * | 1998-06-16 | 1999-12-23 | Boehringer Ingelheim Pharma | Neue Imidazotriazolopyrimidine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
US6448253B1 (en) * | 1998-09-16 | 2002-09-10 | King Pharmaceuticals Research And Development, Inc. | Adenosine A3 receptor modulators |
ATE265459T1 (de) | 1999-09-28 | 2004-05-15 | Otsuka Pharma Co Ltd | Triazolpurin-derivate, medikamentzusammensetzungen, die diese enthalten und mittel, die affinität zum adenosin a3 rezeptor zeigen |
KR100687954B1 (ko) * | 2001-10-15 | 2007-02-27 | 쉐링 코포레이션 | 아데노신 A2a 수용체 길항제로서의이미다조(4,3-e)-1,2,4-트리아졸로(1,5-c) 피리미딘 |
US7196106B2 (en) | 2002-11-05 | 2007-03-27 | Merck & Co., Inc | Cyanothiophene derivatives, compositions containing such compounds and methods of use |
AU2004244906A1 (en) * | 2003-06-10 | 2004-12-16 | Kyowa Hakko Kirin Co., Ltd. | A method of treating an anxiety disorder |
WO2014101113A1 (en) * | 2012-12-28 | 2014-07-03 | Merck Sharp & Dohme Corp. | Piperazine-substituted 7-methoxy-[1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds with a2a antagonist properties |
GB2575490A (en) * | 2018-07-12 | 2020-01-15 | Recordati Ind Chimica E Farmaceutica Spa | P2X3 receptor antagonists |
JP7280883B2 (ja) * | 2018-08-30 | 2023-05-24 | テラ・ストーン株式会社 | キサンチンオキシダーゼを阻害するためのヒドラジノプリン化合物及びトリアゾロプリン化合物 |
CN113692306A (zh) * | 2019-04-03 | 2021-11-23 | 泰拉强石株式会社 | 基于胸腺嘧啶核酸碱基的三唑并嘧啶类及其制造方法 |
WO2022029063A1 (en) | 2020-08-04 | 2022-02-10 | Bayer Aktiengesellschaft | Pyrido[1,2,4]triazolo[1,5-c]pyrimidin-5-amines |
CN116380599B (zh) * | 2023-06-06 | 2023-08-11 | 江苏省沙钢钢铁研究院有限公司 | 一种大尺寸非金属夹杂物的制备方法及其应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0181282A1 (de) * | 1984-10-01 | 1986-05-14 | Ciba-Geigy Ag | Triazolochinazolinverbindungen |
FR2576022B1 (fr) * | 1985-01-11 | 1987-09-11 | Rhone Poulenc Sante | Nouveaux derives de la pristinamycine ii b, leur preparation et les compositions pharmaceutiques qui les contiennent |
JPS62135475A (ja) * | 1985-09-30 | 1987-06-18 | チバ−ガイギ− アクチエンゲゼルシヤフト | 2−置換−e−融合−〔1,2,4〕トリアゾロ−〔1,5−C〕ピリミジン |
DE3677445D1 (de) * | 1985-09-30 | 1991-03-14 | Ciba Geigy Ag | 2-substituierte-e-kondensierte(1,5-c)-pyrimidine, pharmazeutische zubereitungen und ihre verwendung. |
-
1987
- 1987-09-25 DE DE8787810560T patent/DE3781080T2/de not_active Expired - Lifetime
- 1987-09-25 AU AU80271/87A patent/AU612331B2/en not_active Ceased
- 1987-09-25 EP EP87810560A patent/EP0263071B1/en not_active Expired - Lifetime
- 1987-09-25 AT AT87810560T patent/ATE79380T1/de not_active IP Right Cessation
- 1987-09-25 JP JP62505839A patent/JPH06104666B2/ja not_active Expired - Lifetime
- 1987-09-25 ES ES87810560T patent/ES2051772T3/es not_active Expired - Lifetime
- 1987-09-25 WO PCT/EP1987/000547 patent/WO1988002370A1/en active IP Right Grant
- 1987-09-28 CA CA000547940A patent/CA1317590C/en not_active Expired - Fee Related
- 1987-09-29 IE IE261587A patent/IE59815B1/en not_active IP Right Cessation
-
1988
- 1988-05-04 FI FI882081A patent/FI86727C/sv not_active IP Right Cessation
- 1988-05-27 DK DK289888A patent/DK289888A/da not_active Application Discontinuation
-
1989
- 1989-08-03 CN CN89106168A patent/CN1049120A/zh active Pending
-
1992
- 1992-11-13 GR GR920401657T patent/GR3006247T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
DE3781080T2 (de) | 1992-12-24 |
AU8027187A (en) | 1988-04-21 |
EP0263071A1 (en) | 1988-04-06 |
EP0263071B1 (en) | 1992-08-12 |
FI882081A0 (fi) | 1988-05-04 |
JPH06104666B2 (ja) | 1994-12-21 |
WO1988002370A1 (en) | 1988-04-07 |
JPH01500996A (ja) | 1989-04-06 |
CA1317590C (en) | 1993-05-11 |
AU612331B2 (en) | 1991-07-11 |
ES2051772T3 (es) | 1994-07-01 |
IE59815B1 (en) | 1994-04-06 |
DK289888D0 (da) | 1988-05-27 |
FI882081A (fi) | 1988-05-04 |
CN1049120A (zh) | 1991-02-13 |
IE872615L (en) | 1988-03-30 |
GR3006247T3 (sv) | 1993-06-21 |
ATE79380T1 (de) | 1992-08-15 |
FI86727C (sv) | 1992-10-12 |
DE3781080D1 (de) | 1992-09-17 |
DK289888A (da) | 1988-05-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI86727B (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara 2-fenyl- eller halogenfenyl-7,8,9,10 -tetrahydropyrido/e//1,2,4/triazolo/1,5-c/-pyrimidoner. | |
FI84068B (fi) | Foerfarande foer framstaellning av saosom bensodiazepin-receptoragonister/antagonister anvaendbara 2-aryl-cykloalkeno/e//1,2,4/triazolo/1,5-c/pyrimidiner. | |
EP0492485B1 (en) | N-Acyl-2,3-benzodiazepine derivatives, pharmaceutical compositions containing them and process for preparing same | |
KR101478368B1 (ko) | 유기 화합물 | |
JP2648793B2 (ja) | 8a,9−ジヒドロ−1H−ジイミダゾ〔1,5−a:4′,5′−d〕ピリジン誘導体 | |
PL153970B1 (en) | Process for manufacturing novel derivatives of thieno-/1,4/diazepins | |
PL208278B1 (pl) | 4-(2-Butyloamino)-2,7- dimetylo-8-(2- metylo-6- metoksypiryd-3- ylo) pirazolo[1,5-a]-1,3,5- triazyna i jej zastosowanie, kompozycja farmaceutyczna oraz sposób skryningu ligandów dla receptora CRF i sposób wykrywania receptorów CRF | |
BRPI0612075A2 (pt) | pirazolo[1,5-a]pirimidinas halogenadas, processos, usos receptores gaba-a, composições e intermediários | |
US4831013A (en) | 2-substituted-e-fused-[1,2,4]triazolo[1,5-c]pyrimidines, pharmaceutical compositions, and uses thereof | |
US5852190A (en) | Diazepinoindoles as phosphodiesterase IV inhibitors | |
US5968946A (en) | Heterocyclic derivatives useful in treating central nervous system disorders | |
US4503050A (en) | Substituted imidazo[1,2-c]pyrimidines | |
NZ243595A (en) | Imidazo[2,1-b]benzothiazole-3-acetamide derivatives and pharmaceutical compositions | |
US4477450A (en) | Triazolo [4,3-c]pyrimidines substituted by nitrogen-containing heterocyclic rings | |
FI88036B (fi) | Foerfarande foer framstaellning av saosom bensodiazepinreceptoragonister/antagonister anvaendbara 2-aryl-tetrahydro(pyrido- och pyrrolo)/e//1,2,4/triazolo/1,5-c/pyrimidoner | |
Galanski et al. | Studies on the chemistry of thienoanellated O, N-and S, N-containing heterocycles. Part 30: Synthesis and pharmacological properties of thieno [2, 3-b][1, 4] thiazines with potential vasopressin receptor antagonistic activity | |
FI71149C (fi) | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara pyrrolo/3,4-d//2/bensazepinderivat | |
US4372956A (en) | 5, 10-Dihydroimidazo[2,1-b]quinazolines and pharmaceutical compositions containing them | |
JPS62135475A (ja) | 2−置換−e−融合−〔1,2,4〕トリアゾロ−〔1,5−C〕ピリミジン | |
US5057534A (en) | 3-amino-5-arylpyrazole-4-acetic acid derivatives exhibiting therapeutic effects | |
AU2003204221B2 (en) | Dipyridoimidazolderivatives useful in treating central nervous system disorders | |
NZ230436A (en) | Imidazobenzodiazepine derivatives; preparatory processes and pharmaceutical compositions | |
JPH0676414B2 (ja) | ベンゼン縮合複素環化合物 | |
JPH054986A (ja) | ピラゾロキノリン誘導体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application lapsed | ||
MM | Patent lapsed | ||
MM | Patent lapsed |
Owner name: CIBA-GEIGY AG |